Clinical Trial Update: Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis [Phase 2]

View source ↗

Summary

Phase 2 efficacy and safety study of ACP-204 for Lewy body dementia psychosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lewy Body Dementia

Drugs mentioned

• ACP-204

Snippet

Sponsor: ACADIA Pharmaceuticals Inc. | Conditions: Lewy Body Dementia Psychosis | Phase 2 | Status: RECRUITING